Paramount Biosciences has become a global phenomenon. Paramount BioSciences has its foray into pharmaceutical progress; it also invests largely in the healthcare sector. The company’s vision is set at setting up newer companies; the activities of these new companies would chiefly be in concern with biotechnology and existence sciences. Lindsay Rosenwald started to support bio technology industry.  Paramount Biosciences would therefore assist these companies perfect from its inception to its being fully functional as a separate entity. The business has set its eye in developing newer therapeutic medications which the corporation believes has ample marketplace potential.

The company therefore assesses companies globally in the quest for the right candidate it could support. Once the right candidate that fits the company’s bill is identified, the executive Paramount Biosciences has become a global phenomenon. Paramount BioSciences has its foray into pharmaceutical progress; it also invests largely in the healthcare sector. The company’s vision is set at setting up newer companies; the activities of these new companies would chiefly be in concern with biotechnology and existence sciences. Paramount Biosciences would therefore assist these companies perfect from its inception to its being fully functional as a separate entity. The business has set its eye in developing newer therapeutic medications which the corporation believes has ample marketplace potential. The company therefore assesses companies globally in the quest for the right candidate it could support. Once the right candidate that fits the company’s bill is identified, the executive team of Paramount BioSciences takes over.

The expertise of Paramount’s Executive team is this kind of that the team thereon manages the entire advancement cycle of the medication including formulating the manufacturing process, transfer of technology, the pharmacology aspect, the toxicology aspect, clinical improvement aspect of the medication, the regulatory element of the drug, ensuring good quality, commercializing the drug, and hence the existence cycle management. The affiliate of Paramount BioSciences – Paramount BioCapital, Inc, which can be a FINRA registered broker-dealer is involved in the financial funding for this kind of ventures. The Paramount Biosciences is the brainchild of Dr. Lindsay Rosenwald, M.D. who is also the company’s current Chairman and Chief Executive Officer. Dr. Lindsay Rosenwald is a true visionary among his contemporaries. Many a pharmaceutical company nurtured through his Paramount BioSciences company has immensely contributed to humanity as a result of varied medication contributions. Drugs for cancer including leukemia, colon cancer and so on. has hit the marketplace in record time. The medicine Arsenic Trioxide holds a distinctive record for having received the approval of the FDA in the least feasible time. The pharmaceutical companies in the Parmount Biosciences portfolio included Indevus Pharmaceuticals, Keryx Biopharmaceuticals, Polarx, Cougar Biotechnology, Enzymed Corp, Javelin Pharmaceuticals etc. These pharmaceuticals have contributed several a living saving medication. Many among these portfolio companies have been acquired by major companies as a result of million and billion dollar deals depending on the drugs that had been under development in the respective companies.